Close Menu
    What's Hot

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Annuity Sales Set New Quarterly Record in Second Quarter

      August 3, 2026

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    ACLI 2023 Life Insurers Fact Book Shows Industry in Solid Shape

    Life Insurance January 10, 2024By Roger Lawrence
    Share
    Twitter LinkedIn Email

    In early November last year, industry group the American Council of Life Insurers (ACLI) published its annual Life Insurers Fact Book, the organisation’s deep dive in to a range of sub-categories of the US life insurance industry.

    As always, there are many notable takeaways from the document. Some of the most notable include the following:

    • After a record high for total claims payments made on life insurance contracts in 2021, 2022 saw a fall back. Death claims paid on individual life contracts fell 7.7% from $73bn to $66bn
    • Surrender payments rose 5.3% from $27.4bn to $28.8bn
    • Aggregate assets of insurers receded to $8.3trn from £8.7trn, but they’re still up from 2020 which stood at $8.2trn
    • Insurers’ total Interest Maintenance Reserves (IMR) fell 43.3% to $28bn
    • Insurers’ total Asset Valuation Reserve (AVR) fell 8.8% to $88bn
    • Capital Ratios including AVR dropped to 10.5% from 11.1% and the measure for their excess surplus capital compared to the regulatory minimum (the Risk Based Capital Ratio or RBC) dropped marginally from 443% to 426%
    • Premium income on life insurance products rose 3.3% from $165bn to $170bn (individual contracts being $137bn to $139bn of which $19bn was the first year’s premium on new regular premium contracts which was marginally down from $21bn in 2021)

    These observations are notable for many reasons. The economic backdrop to 2022 was one which saw most central banks, including the Fed, only just starting to react seriously to the emerging inflationary risk with regular hikes in central bank lending rate. Russia’s attack on Ukraine causing an energy price squeeze compounded the inflationary pressures, leading to the yield on benchmark 10-year US Treasuries rising from 1.5-% to 3.9%. The S&P 500 fell from 4,766 at the start of the year to 3,840, a drop of 19.5% that is very close to the 20% ‘full-blown bear market’ territory.

    Meanwhile, by the end of the year, US price inflation had fallen to 6.4% after starting the year at 7.5% and peaking at 9.1% mid-year. Despite the downward trend in H2, consumers had experienced a year of prices rising at levels they had grown unaccustomed to over more than a decade and the effect hit household budgets hard.

    An increasing proportion of life insurer’s business is from the annuity stream which is primarily matched by bonds and other credit assets. Whilst the value of those assets fell as yields rose, so too did the liabilities. The drop in bond values hit the IMR reserves hard from capital losses, but the impact on the RBC ratios was relatively small, demonstrating how resilient a life insurer is to market volatility if they maintain well-matched assets.

    Equities represent a relatively low fraction of total assets although they do tend to support proportionately more of the life insurance book, and whilst the drop in equity values was less than it was for bonds, 2022 was not a good year. Tech stocks, which have an outsized influence on equity index performance, have had a roller coaster ride since March 2020, with valuations, having surged in 2021, unwinding significantly in 2022, nearly all of which has been captured in this year’s ACLI figures – and notably in the drop in insurers’ AVRs.

    Death claims dropped in 2022. It’s likely that the surge in Covid-related claims in 2020 and 2021 falling away had an impact here. The ACLI report publishes insurer’s experiential mortality rates (but only a year in arrears, so the 2022 values are not yet available) and the age-standardised mortality rates insurers experienced in the years 2018-21 were 7.2, 7.2, 8.4 and 8.4 (per 1,000 lives, males and females combined). The step up between 2019 and 2020 is 16.7%, a significant uplift, likely due to Covid. The drop in the value of claims paid by only 7.7% suggests that the mortality experience in 2022 still is being affected by Covid, either directly, or from the emerging longer-term effects of people with early stage diseases such as cancer not presenting in a timely manner during lockdowns.

    In contrast to death claims, surrender payouts rose by value. The numbers of surrenders are not provided in the ACLI report, so it’s not possible to be certain that a rise in the surrender value also means a rise in the actual numbers of surrenders. However, it is hard to see policies that attract surrender values rising substantially in value during the year because where policies have accumulated value that can be paid out as a surrender value, the value per policy is unlikely to have been noticeably larger in 2022 than 2021, or certainly not 5.3% or more larger. If this theory is correct, this means that an increased number of policies were surrendered in 2022.

    An obvious cause for the rise would be financial pressures on households and, whilst US jobs numbers have held up, there will have been pockets of job losses potentially forcing policy cancellation. Weaker economic growth into 2023 and darker recessionary clouds on the horizon suggest some continuance of these patterns for a while yet, which means that the life settlement industry stands to help more policyholders unlock further value during this period.

    If times are bad for many policyholders, leading to higher lapse rates, then it ought to be true that new product sales would be impacted. The ACLI figures do bear out a small drop in new regular premiums but, as with the surrender value data, we don’t have information on numbers of new policies written in 2022 (we have only the aggregate premiums). It is not entirely inconceivable that certain product types have witnessed reductions in sales whilst others have grown as customers requiring protection products seek out the cheapest options, and Universal Whole of Life with age-based charging may have a marginal edge over level premium alternatives. The reported figures may just be a case of people opting for smaller face amounts to fit with their current budgets. Either way, the drop in new regular premiums is not unexpected in a difficult economic climate and a small reduction in such a difficult year is not a harbinger of a systemic decline in new policy sales.

    Overall, the top-line data from the ACLI’s 2023 Life Insurers’ Fact Book suggest an industry that has weathered the dual impacts of Covid and the macroeconomic challenges of the past almost four years rather well.

    Roger Lawrence is Managing Partner at WL Consulting


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association

    2024 - January Analysis Commentary Volume 3 Issue 1 - January 2024
    Share. Twitter LinkedIn Email

    Related Posts

    From Policy Ambition to Operational Reality: Building the Foundations of the UK’s Next Pensions Era

    June 24, 2026By Peter Roos

    Shaping the Future of Health Insurance Through Innovation and Analytics

    June 10, 2026By Jessica Plewes and Lisa Balboa

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble

    Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

    April 9, 2026By Liam Bodemeaid
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.